While upregulation of MRN complex has been associated with a high tumor grade, chemo/radiotherapy resistance, and poor overall and progression-free survival, deficiency in MRE11 predicts a better prognosis [96,97,98,99]. The gene discussed is MRE11; the disease is neoplasm.